{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:40:06Z","timestamp":1793400006868,"version":"4.5.0"},"reference-count":129,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Over the past two decades, metabolic syndrome (MetS) and infections caused by multidrug-resistant (MDR) pathogens have emerged as converging global health challenges. Traditionally investigated as separate entities, accumulating evidence increasingly supports a bidirectional relationship between them, mediated by chronic inflammation, immune dysregulation, gut microbiota alterations, and antibiotic-driven expansion of the resistome. This narrative review examines the complex immunometabolic interplay linking MetS and MDR infections, focusing on molecular mechanisms, clinical implications, and prospective research directions. A systematic literature search was conducted using major databases, including PubMed and Scopus, targeting studies from the last 15 years that explore the interface between metabolic dysfunction and antimicrobial resistance. Particular attention is given to key immunometabolic pathways such as the IRS\u2013PI3K\u2013AKT\u2013mTOR axis; the contribution of visceral adiposity and Toll-like receptor (TLR)-mediated inflammation; and the role of gut dysbiosis in augmenting both susceptibility to infections and metabolic derangements. Evidence is presented supporting the hypothesis that MetS increases host vulnerability to MDR pathogens, while chronic MDR infections may reciprocally induce systemic metabolic reprogramming. Viral infections with established metabolic sequelae (e.g., HIV, hepatitis C virus [HCV], and cytomegalovirus [CMV]) are also considered to broaden the conceptual framework. Although current data remain largely associative and fragmented, the emerging MetS\u2013MDR syndemic model poses substantial challenges for translational research, antimicrobial stewardship, and personalized therapeutic strategies. Recognizing this reciprocal relationship is pivotal for refining infection risk stratification, optimizing treatment, and informing public health policies. Further investigations are warranted to elucidate the magnitude and directionality of this association and to identify predictive immunometabolic biomarkers that may guide targeted interventions in high-risk populations.<\/jats:p>","DOI":"10.3390\/biomedicines13061343","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:22:41Z","timestamp":1748596961000},"page":"1343","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1239-7012","authenticated-orcid":false,"given":"Carlo","family":"Acierno","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Azienda Ospedaliera Regionale San Carlo, 85100 Potenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3320-3878","authenticated-orcid":false,"given":"Riccardo","family":"Nevola","sequence":"additional","affiliation":[{"name":"Liver Unit, Azienda Ospedaliera di Rilievo Nazionale S. G. Moscati, \u201cA. Landolfi\u201d Hospital, 83029 Solofra, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fannia","family":"Barletta","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Azienda Ospedaliera Regionale San Carlo, 85100 Potenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-3821","authenticated-orcid":false,"given":"Luca","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Science \u201cVincenzo Tiberio\u201d, University of Molise, 86100 Campobasso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-7848","authenticated-orcid":false,"given":"Ferdinando Carlo","family":"Sasso","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-4912","authenticated-orcid":false,"given":"Luigi Elio","family":"Adinolfi","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7761-7533","authenticated-orcid":false,"given":"Alfredo","family":"Caturano","sequence":"additional","affiliation":[{"name":"Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1080\/1040841X.2024.2313024","article-title":"Antibiotic resistance: A global crisis, problems and solutions","volume":"50","author":"Aggarwal","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Santajit, S., and Indrawattana, N. (2016). Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. BioMed Res. Int., 2016.","DOI":"10.1155\/2016\/2475067"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12858","article-title":"Immunometabolism: From basic mechanisms to translation","volume":"295","author":"Makowski","year":"2020","journal-title":"Immunol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Geerling, E., Hameed, M., Weger-Lucarelli, J., and Pinto, A.K. (2022). Metabolic syndrome and aberrant immune responses to viral infection and vaccination: Insights from small animal models. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1015563"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2011.151","article-title":"Management of the metabolic effects of HIV and HIV drugs","volume":"8","author":"Brown","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.3748\/wjg.v27.i26.3971","article-title":"Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion","volume":"27","author":"Shi","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100902","DOI":"10.1016\/S2666-5247(24)00134-4","article-title":"WHO global research priorities for antimicrobial resistance in human health","volume":"5","author":"Bertagnolio","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_9","first-page":"100331","article-title":"Multidrug resistant Acinetobacter baumannii: A study on its pathogenesis and therapeutics","volume":"8","author":"Mukhopadhyay","year":"2025","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Jurado-Mart\u00edn, I., Sainz-Mej\u00edas, M., and McClean, S. (2021). Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063128"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.13005\/bbra\/3252","article-title":"Metabolic Impairment of Natural Killer Cells in Type 2 Diabetes (T2D) Individuals: A Double-Edged Sword Elevating Susceptibility to Infections and Cancer","volume":"21","author":"Almutairi","year":"2024","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/omi.12072","article-title":"Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity","volume":"30","author":"Richards","year":"2015","journal-title":"Mol. Oral Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2337\/db23-0447","article-title":"Multiomics Analyses With Stool-Type Stratification in Patient Cohorts and Blautia Identification as a Potential Bacterial Modulator in Type 2 Diabetes Mellitus","volume":"73","author":"Guo","year":"2024","journal-title":"Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2147\/IDR.S391349","article-title":"Epidemiological Features and Impact of High Glucose Level on Virulence Gene Expression and Serum Resistance of Klebsiella pneumoniae Causing Liver Abscess in Diabetic Patients","volume":"16","author":"Tang","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Huang, J., Yi, M., Yuan, Y., Xia, P., Yang, B., Liao, J., Dang, Z., Luo, S., and Xia, Y. (2022). Emergence of a Fatal ST11-KL64 Tigecycline-Resistant Hypervirulent Klebsiella pneumoniae Clone Cocarrying blaNDM and blaKPC in Plasmids. Garcia-Solache MA, curatore. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02539-22"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10020-025-01074-z","article-title":"Endocrine and metabolic alterations in response to systemic inflammation and sepsis: A review article","volume":"31","author":"Mehdi","year":"2025","journal-title":"Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid\u2013induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"ckaa165.315","DOI":"10.1093\/eurpub\/ckaa165.315","article-title":"Multidrug-resistant organism infections and mortality: Estimates from a large Italian hospital","volume":"30","author":"Moro","year":"2020","journal-title":"Eur. J. Public Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/QCO.0000000000000045","article-title":"Antibiotic therapy of pneumonia in the obese patient: Dosing and delivery","volume":"27","author":"Arabi","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-024-00563-5","article-title":"Metabolic syndrome","volume":"10","author":"Neeland","year":"2024","journal-title":"Nat. Rev. Dis. Primer."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.37349\/emed.2020.00019","article-title":"Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Pathophysiological Mechanisms Shared Between the Two Faces of the Same Coin","volume":"1","author":"Acierno","year":"2020","journal-title":"Explor. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00424-024-03051-7","article-title":"Epidemiology of metabolic syndrome","volume":"477","author":"Pigeot","year":"2025","journal-title":"Pfl\u00fcg. Arch.-Eur. J. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the Prevalence of Metabolic Syndrome in the United States, 2011\u20132016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"de Siqueira Valadares, L.T., de Souza, L.S.B., Salgado J\u00fanior, V.A., de Freitas Bonomo, L., de Macedo, L.R., and Silva, M. (2022). Prevalence of metabolic syndrome in Brazilian adults in the last 10 years: A systematic review and meta-analysis. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-12753-5"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gutierrez-Montiel, D., Guerrero-Barrera, A.L., Ram\u00edrez-Castillo, F.Y., Galindo-Guerrero, F., Ornelas-Garc\u00eda, I.G., Ch\u00e1vez-Vela, N.A., Costa, M.d.O., Avelar-Gonzalez, F.J., Moreno-Flores, A.C., and Vazquez-Pedroza, E. (2024). Guava Leaf Extract Exhibits Antimicrobial Activity in Extensively Drug-Resistant (XDR) Acinetobacter baumannii. Molecules, 30.","DOI":"10.3390\/molecules30010070"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.ijo.0803354","article-title":"Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China","volume":"31","author":"Wang","year":"2007","journal-title":"Int. J. Obes."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/2047487314525529","article-title":"Metabolic syndrome across Europe: Different clusters of risk factors","volume":"22","author":"Scuteri","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-5448.2007.00271.x","article-title":"The metabolic syndrome in children and adolescents\u2014An IDF consensus report","volume":"8","author":"Zimmet","year":"2007","journal-title":"Pediatr. Diabetes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/met.2012.0122","article-title":"The Prevalence of Metabolic Syndrome in Children: A Systematic Review of the Literature","volume":"11","author":"Friend","year":"2013","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the Metabolic Syndrome in Children and Adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/icb.2011.110","article-title":"The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance","volume":"90","author":"Winer","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"802078","DOI":"10.1155\/2010\/802078","article-title":"The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases","volume":"2010","author":"Balistreri","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s42255-021-00470-z","article-title":"Metabolic Messengers: Tumour necrosis factor","volume":"3","author":"Sethi","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A.J., Gojobori, T., and Isenovic, E.R. (2021). Leptin and obesity: Role and clinical implication. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.585887"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.14341\/probl12827","article-title":"Adiponectin: A pleiotropic hormone with multifaceted roles","volume":"67","author":"Shklyaev","year":"2021","journal-title":"Probl. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"289645","DOI":"10.1155\/2010\/289645","article-title":"Chronic Inflammation in Obesity and the Metabolic Syndrome","volume":"2010","author":"Monteiro","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-sensing receptors in inflammation and diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Caturano, A., Rocco, M., Tagliaferri, G., Piacevole, A., Nilo, D., Di Lorenzo, G., Iadicicco, I., Donnarumma, M., Galiero, R., and Acierno, C. (2025). Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications. Antioxidants, 14.","DOI":"10.3390\/antiox14010072"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Caturano, A., Acierno, C., Nevola, R., Pafundi, P.C., Galiero, R., Rinaldi, L., Salvatore, T., Adinolfi, L.E., and Sasso, F.C. (2021). Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes, 9.","DOI":"10.3390\/pr9010135"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for Insulin Resistance: Common Threads and Missing Links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI88876","article-title":"Role of innate and adaptive immunity in obesity-associated metabolic disease","volume":"127","author":"McLaughlin","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Acierno, C., Nevola, R., Rinaldi, L., Sasso, F.C., Adinolfi, L.E., and Caturano, A. (2025). The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease. Livers, 5.","DOI":"10.3390\/livers5020017"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zhang, F., and Cheng, W. (2022). The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies. Antibiotics, 11.","DOI":"10.3390\/antibiotics11091215"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_51","unstructured":"World Health Organization (2015). Global Action Plan on Antimicrobial Resistance, World Health Organization. Available online: https:\/\/iris.who.int\/handle\/10665\/193736."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Karampatakis, T., Tsergouli, K., and Behzadi, P. (2023). Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options. Antibiotics, 12.","DOI":"10.3390\/antibiotics12020234"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100232","DOI":"10.1016\/j.slasd.2025.100232","article-title":"Antimicrobial Resistance: Linking Molecular Mechanisms to Public Health Impact","volume":"33","author":"Muteeb","year":"2025","journal-title":"SLAS Discov. Adv. Sci. Drug Discov."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_58","unstructured":"Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(24)02081-6","article-title":"Multidrug-resistant Gram-negative bacterial infections","volume":"405","author":"Macesic","year":"2025","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/22221751.2022.2030196","article-title":"Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: A systematic review and meta-analysis","volume":"11","author":"Ayobami","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_61","unstructured":"(2025, May 16). Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2023-2021-data."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"de Kraker, M.E.A., Stewardson, A.J., and Harbarth, S. (2016). Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002184"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.21037\/apm-21-338","article-title":"Predictors of mortality in patients with carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis and a systematic review","volume":"10","author":"Qian","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"ref_64","first-page":"e000370","article-title":"Antibiotic resistance in Pseudomonas aeruginosa and adaptation to complex dynamic environments","volume":"6","author":"Sommer","year":"2020","journal-title":"Microb. Genom."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zhao, L., Pu, J., Liu, Y., Cai, H., Han, M., Yu, Y., and Tang, J. (2025). High prevalence of carbapenem-resistant Pseudomonas aeruginosa and identification of a novel VIM-type metallo-\u03b2-lactamase, VIM-92, in clinical isolates from northern China. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1543509"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MCC.0000000000000974","article-title":"Update on Staphylococcus aureus bacteraemia","volume":"28","author":"Tabah","year":"2022","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic","volume":"23","author":"David","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41579-024-01058-6","article-title":"Enterococcus faecium: Evolution, adaptation, pathogenesis and emerging therapeutics","volume":"22","author":"Wei","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"O\u2019Toole, R.F., Leong, K.W., Cumming, V., and Van Hal, S.J. (2023). Vancomycin-resistant Enterococcus faecium and the emergence of new sequence types associated with hospital infection. Res. Microbiol., 174.","DOI":"10.1016\/j.resmic.2023.104046"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the Enterococcus: Beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3201\/eid2309.161710","article-title":"Cost of Nosocomial Outbreak Caused by NDM-1-Containing Klebsiella pneumoniae in The Netherlands, October 2015\u2013January 2016","volume":"3","author":"Mollers","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12979-024-00414-7","article-title":"The interplay between obesity, immunosenescence, and insulin resistance","volume":"21","author":"Shimi","year":"2024","journal-title":"Immun. Ageing"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Fredriksen, S., de Warle, S., van Baarlen, P., Boekhorst, J., and Wells, J.M. (2023). Resistome expansion in disease-associated human gut microbiomes. Microbiome, 11.","DOI":"10.1186\/s40168-023-01610-1"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/MMBR.67.2.226-237.2003","article-title":"Virus entry, assembly, budding, and membrane rafts","volume":"67","author":"Chazal","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Iqbal, M.Z., He, P., He, P., Wu, Y., Munir, S., and He, Y. (2024). The Response of Murine Gut Microbiome in the Presence of Altered rpoS Gene of Klebsiella pneumoniae. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179222"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/MOL.0b013e32832fa5c4","article-title":"Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome","volume":"20","author":"Fessler","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Todd, K., Gunter, K., Bowen, J.M., Holmes, C.L., Tilston-Lunel, N.L., and Vornhagen, J. (2024). Type-2 diabetes mellitus enhances Klebsiella pneumoniae pathogenesis. BioRxiv, BioRxiv:2024.05.31.596766.","DOI":"10.1101\/2024.05.31.596766"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e16101","DOI":"10.1111\/liv.16101","article-title":"Association between MASLD and increased risk of serious bacterial infections requiring hospital admission: A meta-analysis","volume":"45","author":"Mantovani","year":"2024","journal-title":"Liver Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/dc09-2215","article-title":"Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection","volume":"33","author":"Allard","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc12572","article-title":"The effect of diabetes mellitus on the association between measures of glycaemiccontrol and ICU mortality: A retrospective cohort study","volume":"17","author":"Sechterberger","year":"2013","journal-title":"Crit. Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13756-022-01204-w","article-title":"Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: An eight-year retrospective study","volume":"11","author":"Chen","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.2147\/IDR.S475073","article-title":"Prognostic Factors That Affect Mortality Patients with Acinetobacter baumannii Bloodstream Infection","volume":"17","author":"Huang","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Alenazi, T.A., Bin Shaman, M.S., Suliman, D.M., Alanazi, T.A., Altawalbeh, S.M., Alshareef, H., Lahreche, D.I., Al-Azzam, S., Araydah, M., and Karasneh, R. (2023). The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection. Healthcare, 11.","DOI":"10.3390\/healthcare11040487"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s00125-024-06102-x","article-title":"Diabetes and infection: Review of the epidemiology, mechanisms and principles of treatment","volume":"67","author":"Holt","year":"2024","journal-title":"Diabetologia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archsurg.2010.179","article-title":"Postoperative Hyperglycemia and Surgical Site Infection in General Surgery Patients","volume":"145","author":"Ata","year":"2010","journal-title":"Arch. Surg."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"ofz400","DOI":"10.1093\/ofid\/ofz400","article-title":"Association Between Estimated Pharmacokinetic\/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections","volume":"6","author":"Bunnell","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_88","first-page":"101220","article-title":"Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: Findings from three nationwide prospective studies","volume":"51","year":"2025","journal-title":"Lancet Reg. Health-Eur."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13054-016-1360-z","article-title":"Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: A systematic review and meta-analysis","volume":"20","author":"Pepper","year":"2016","journal-title":"Crit. Care"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"M\u00e4rtson, A.-G., Barber, K.E., Crass, R.L., Hites, M., Kloft, C., Kuti, J.L., Nielsen, E.I., Pai, M.P., Zeitlinger, M., and Roberts, J.A. (2025). The pharmacokinetics of antibiotics in patients with obesity: A systematic review and consensus guidelines for dose adjustments. Lancet Infect. Dis., in press.","DOI":"10.1016\/S1473-3099(25)00155-0"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Gorham, J., Taccone, F.S., and Hites, M. (2023). Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients. Antibiotics, 12.","DOI":"10.3390\/antibiotics12071099"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Davido, B., Merrick, B., Kuijper, E., Benech, N., Biehl, L.M., Corcione, S., and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI) (2025). How can the gut microbiome be targeted to fight multidrug-resistant organisms?. Lancet Microbe., 101063.","DOI":"10.1016\/j.lanmic.2024.101063"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e0050923","DOI":"10.1128\/iai.00509-23","article-title":"Triple threat: How diabetes results in worsened bacterial infections. Richardson AR, curatore","volume":"92","author":"Darwitz","year":"2024","journal-title":"Infect. Immun."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Zhao, X., Zheng, J., Wang, J., Li, B., and Huang, W. (2024). Inhibition of Hyperglycemia and Hyperlipidemia by Blocking Toll-like Receptor 4: Comparison of Wild-Type and Toll-like Receptor 4 Gene Knockout Mice on Obesity and Diabetes Modeling. Biology, 13.","DOI":"10.3390\/biology13010063"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.taap.2007.06.010","article-title":"HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis","volume":"224","author":"Jiang","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1093\/infdis\/jiae210","article-title":"Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis","volume":"230","author":"Selvamani","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2478317","DOI":"10.1080\/07853890.2025.2478317","article-title":"Exploring the role of gut microbiota in antibiotic resistance and prevention","volume":"57","author":"Dongre","year":"2025","journal-title":"Ann. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.molcel.2020.03.001","article-title":"Immune-Microbiota Interplay and Colonization Resistance in Infection","volume":"78","author":"Leshem","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Li, W., Lin, X., Liang, H., Wu, Z., Wang, M., Sun, J., Li, X., He, W., Gao, X., and Hu, T. (2024). Genomic and functional diversity of the human-derived isolates of Faecalibacterium. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1379500"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12263-021-00703-6","article-title":"Gut microbiota in patients with obesity and metabolic disorders\u2014A systematic review","volume":"17","author":"Xu","year":"2022","journal-title":"Genes Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"eabo2750","DOI":"10.1126\/scitranslmed.abo2750","article-title":"Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement","volume":"15","author":"Woodworth","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.chembiol.2024.12.005","article-title":"Metabolic tug-of-war: Microbial metabolism shapes colonization resistance against enteric pathogens","volume":"32","author":"Jones","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/phar.2769","article-title":"Comprehensive guidance for antibiotic dosing in obese adults: 2022 update","volume":"43","author":"Meng","year":"2023","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/idr15030025","article-title":"Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)\u2014A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)","volume":"15","author":"Merrick","year":"2023","journal-title":"Infect. Dis. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/diabetology5040031","article-title":"Metabolic Syndrome Drug Therapy: The Potential Interplay of Pharmacogenetics and Pharmacokinetic Interactions in Clinical Practice: A Narrative Review","volume":"5","year":"2024","journal-title":"Diabetology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e0171923","DOI":"10.1128\/aac.01719-23","article-title":"Updated antimicrobial dosing recommendations for obese patients","volume":"68","author":"Mejuto","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2147\/DMSO.S449494","article-title":"A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease","volume":"17","author":"Jiang","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijantimicag.2016.09.010","article-title":"Pharmacokinetics\/pharmacodynamics of colistin and polymyxin B: Are we there yet?","volume":"48","author":"Tran","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13054-016-1426-y","article-title":"Antibiotic dosing in obesity: A BIG challenge","volume":"20","author":"Hanrahan","year":"2016","journal-title":"Crit. Care"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40560-023-00699-8","article-title":"Efficacy of therapeutic drug monitoring-based antibiotic regimen in critically ill patients: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Takahashi","year":"2023","journal-title":"J. Intensiv. Care"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmi.2017.08.026","article-title":"What is antimicrobial stewardship?","volume":"23","author":"Dyar","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New Zealand Intensive Care Society Clinical Trials Group, and the Australasian Society for Infectious Diseases Clinical Research Network, Daneman, N., Rishu, A., Pinto, R., Rogers, B.A., Shehabi, Y., Parke, R., Cook, D., Arabi, Y., and Muscedere, J. (2025). Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections. N. Engl. J. Med., 392, 1065\u20131078.","DOI":"10.1056\/NEJMoa2404991"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Ferreira, C., Vieira, P., S\u00e1, H., Malva, J., Castelo-Branco, M., Reis, F., and Viana, S. (2024). Polyphenols: Immunonutrients tipping the balance of immunometabolism in chronic diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1360065"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Tummolo, A., and Melpignano, L. (2023). The Reciprocal Interplay between Infections and Inherited Metabolic Disorders. Microorganisms, 11.","DOI":"10.3390\/microorganisms11102545"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13756-024-01428-y","article-title":"Development and validation of machine learning models to predict MDRO colonization or infection on ICU admission by using electronic health record data","volume":"13","author":"Li","year":"2024","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Wp, S.E., Norhidayah, M., and Ar, M.N.A. (2025). Factors associated with multidrug-resistant organism (MDRO) mortality: An analysis from the national surveillance of multidrug-resistant organism, 2018\u20132022. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-024-10338-8"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","article-title":"Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and meta-analysis","volume":"7","author":"Raman","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Tarantino, G., and Citro, V. (2024). Could Adverse Effects of Antibiotics Due to Their Use\/Misuse Be Linked to Some Mechanisms Related to Nonalcoholic Fatty Liver Disease?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25041993"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., and Assi, H.I. (2022). Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020786"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bcp.14461","article-title":"Monitoring the community use of antibiotics in Italy within the National Action Plan on antimicrobial resistance","volume":"87","author":"Cangini","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"19525","DOI":"10.2807\/ese.15.12.19525-en","article-title":"Risk groups and other target groups-preliminary ECDC guidance for developing influenza vaccination recommendations for the season 2010-11","volume":"15","author":"Nokleby","year":"2010","journal-title":"Euro Surveill."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijid.2020.02.040","article-title":"Who and when to vaccinate against influenza","volume":"93","author":"Buchy","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QCO.0000000000000246","article-title":"Pneumococcal vaccination","volume":"29","author":"Amaro","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2434685","DOI":"10.1080\/19490976.2024.2434685","article-title":"Development of a Caco-2-based intestinal mucosal model to study intestinal barrier properties and bacteria\u2013mucus interactions","volume":"17","author":"Floor","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_127","unstructured":"Schuh, M.G., Hesse, J., and Sieber, S.A. (2025). AI-guided Antibiotic Discovery Pipeline from Target Selection to Compound Identification. arXiv, Available online: http:\/\/arxiv.org\/abs\/2504.11091."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Yang, S.Y., Han, S.M., Lee, J.Y., Kim, K.S., Lee, J.E., and Lee, D.W. (2025). Advancing Gut Microbiome Research: The Shift from Metagenomics to Multi-Omics and Future Perspectives. J. Microbiol. Biotechnol., 35.","DOI":"10.4014\/jmb.2412.12001"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Yadegar, A., Bar-Yoseph, H., Monaghan, T.M., Pakpour, S., Severino, A., Kuijper, E.J., Smits, W.K., Terveer, E.M., Neupane, S., and Nabavi-Rad, A. (2024). Fecal microbiota transplantation: Current challenges and future landscapes. Clin. Microbiol. Rev., 37.","DOI":"10.1128\/cmr.00060-22"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1343\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:44:01Z","timestamp":1760031841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/6\/1343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":129,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["biomedicines13061343"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13061343","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}